These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 37024667)
41. Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors. Nettersheim D; Berger D; Jostes S; Skowron M; Schorle H J Cell Mol Med; 2019 Jan; 23(1):670-679. PubMed ID: 30460772 [TBL] [Abstract][Full Text] [Related]
42. Targeting histone deacetylases in testicular germ cell tumours: an encouraging treatment approach for the future Tavares NT; Henrique R; Jerónimo C; Lobo J J Pathol; 2023 Feb; 259(2):115-118. PubMed ID: 36426822 [TBL] [Abstract][Full Text] [Related]
43. Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent. Piulats JM; Vidal A; García-Rodríguez FJ; Muñoz C; Nadal M; Moutinho C; Martínez-Iniesta M; Mora J; Figueras A; Guinó E; Padullés L; Aytés À; Molleví DG; Puertas S; Martínez-Fernández C; Castillo W; Juliachs M; Moreno V; Muñoz P; Stefanovic M; Pujana MA; Condom E; Esteller M; Germà JR; Capella G; Farré L; Morales A; Viñals F; García-Del-Muro X; Cerón J; Villanueva A Clin Cancer Res; 2018 Aug; 24(15):3755-3766. PubMed ID: 29618620 [No Abstract] [Full Text] [Related]
44. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line. Spierings DC; de Vries EG; Vellenga E; de Jong S Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464 [TBL] [Abstract][Full Text] [Related]
45. Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells. Gerwing M; Jacobsen C; Dyshlovoy S; Hauschild J; Rohlfing T; Oing C; Venz S; Oldenburg J; Oechsle K; Bokemeyer C; von Amsberg G; Honecker F J Cancer Res Clin Oncol; 2016 Sep; 142(9):1979-94. PubMed ID: 27424191 [TBL] [Abstract][Full Text] [Related]
46. Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours. Fazal Z; Singh R; Fang F; Bikorimana E; Baldwin H; Corbet A; Tomlin M; Yerby C; Adra N; Albany C; Lee S; Freemantle SJ; Nephew KP; Christensen BC; Spinella MJ Epigenetics; 2021 Oct; 16(10):1071-1084. PubMed ID: 33126827 [TBL] [Abstract][Full Text] [Related]
47. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells. Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479 [TBL] [Abstract][Full Text] [Related]
49. The role of reactive oxygen species in cisplatin-induced apoptosis in human malignant testicular germ cell lines. Schweyer S; Soruri A; Heintze A; Radzun HJ; Fayyazi A Int J Oncol; 2004 Dec; 25(6):1671-6. PubMed ID: 15547704 [TBL] [Abstract][Full Text] [Related]
50. The component of the m Miranda-Gonçalves V; Lobo J; Guimarães-Teixeira C; Barros-Silva D; Guimarães R; Cantante M; Braga I; Maurício J; Oing C; Honecker F; Nettersheim D; Looijenga LHJ; Henrique R; Jerónimo C J Exp Clin Cancer Res; 2021 Aug; 40(1):268. PubMed ID: 34446080 [TBL] [Abstract][Full Text] [Related]
52. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ. Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509 [TBL] [Abstract][Full Text] [Related]
53. Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications. Kalavska K; Conteduca V; De Giorgi U; Mego M Curr Cancer Drug Targets; 2018; 18(10):967-978. PubMed ID: 29295694 [TBL] [Abstract][Full Text] [Related]
54. Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors. Feldman DR; Iyer G; Van Alstine L; Patil S; Al-Ahmadie H; Reuter VE; Bosl GJ; Chaganti RS; Solit DB Clin Cancer Res; 2014 Jul; 20(14):3712-20. PubMed ID: 24812411 [TBL] [Abstract][Full Text] [Related]
55. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. Burger H; Nooter K; Boersma AW; Kortland CJ; Stoter G Br J Cancer; 1998 May; 77(10):1562-7. PubMed ID: 9635829 [TBL] [Abstract][Full Text] [Related]
56. Assessing Homologous Recombination and Interstrand Cross-Link Repair in Embryonal Carcinoma Testicular Germ Cell Tumor Cell Lines. Cavallo F; Caggiano C; Jasin M; Barchi M Methods Mol Biol; 2021; 2195():113-123. PubMed ID: 32852761 [TBL] [Abstract][Full Text] [Related]
57. PCPH expression is an early event in the development of testicular germ cell tumors. Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363 [TBL] [Abstract][Full Text] [Related]
58. Molecular and cell biology of testicular germ cell tumors. Chieffi P; Franco R; Portella G Int Rev Cell Mol Biol; 2009; 278():277-308. PubMed ID: 19815181 [TBL] [Abstract][Full Text] [Related]
59. Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity. Awuah SG; Riddell IA; Lippard SJ Proc Natl Acad Sci U S A; 2017 Jan; 114(5):950-955. PubMed ID: 28096358 [TBL] [Abstract][Full Text] [Related]
60. Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours. Nitzsche B; Gloesenkamp C; Schrader M; Ocker M; Preissner R; Lein M; Zakrzewicz A; Hoffmann B; Höpfner M Br J Cancer; 2010 Jun; 103(1):18-28. PubMed ID: 20551952 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]